131 related articles for article (PubMed ID: 30637850)
1. Relationship between Selective Serotonin Reuptake Inhibitors and Risk of Dental Implant Failure.
Carr AB; Gonzalez RLV; Jia L; Lohse CM
J Prosthodont; 2019 Mar; 28(3):252-257. PubMed ID: 30637850
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: a cohort study.
Wu X; Al-Abedalla K; Rastikerdar E; Abi Nader S; Daniel NG; Nicolau B; Tamimi F
J Dent Res; 2014 Nov; 93(11):1054-61. PubMed ID: 25186831
[TBL] [Abstract][Full Text] [Related]
3. Selective Serotonin Reuptake Inhibitors and Dental Implant Failure: A Systematic Review and Meta-Analysis.
Shariff JA; Gurpegui Abud D; Bhave MB; Tarnow DP
J Oral Implantol; 2023 Aug; 49(4):436-443. PubMed ID: 37527173
[TBL] [Abstract][Full Text] [Related]
4. Does the Intake of Selective Serotonin Reuptake Inhibitors Negatively Affect Dental Implant Osseointegration? A Retrospective Study.
Altay MA; Sindel A; Özalp Ö; Yildirimyan N; Kader D; Bilge U; Baur DA
J Oral Implantol; 2018 Aug; 44(4):260-265. PubMed ID: 29517407
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Implication of Selective Serotonin Reuptake Inhibitors in Osseointegration of Dental Implants: A 5-year Retrospective Study.
Deepa ; Mujawar K; Dhillon K; Jadhav P; Das I; Singla YK
J Contemp Dent Pract; 2018 Jul; 19(7):842-846. PubMed ID: 30066689
[TBL] [Abstract][Full Text] [Related]
6. Risk of Dental Implant Failure Associated With Medication Use.
Carr AB; Revuru VS; Lohse CM
J Prosthodont; 2019 Aug; 28(7):743-749. PubMed ID: 29508502
[TBL] [Abstract][Full Text] [Related]
7. Effects of different antidepressant classes on dental implant failure: A retrospective clinical study.
Hakam AE; Vila G; Duarte PM; Mbadu MP; Ai Angary DS; Shuwaikan H; Aukhil I; Neiva R; da Silva HDP; Chang J
J Periodontol; 2021 Feb; 92(2):196-204. PubMed ID: 32725908
[TBL] [Abstract][Full Text] [Related]
8. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.
Czaja AS; Valuck RJ; Anderson HD
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):607-14. PubMed ID: 23456956
[TBL] [Abstract][Full Text] [Related]
9. Is the intake of selective serotonin reuptake inhibitors associated with an increased risk of dental implant failure?
Chrcanovic BR; Kisch J; Albrektsson T; Wennerberg A
Int J Oral Maxillofac Surg; 2017 Jun; 46(6):782-788. PubMed ID: 28222946
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors and dental implant failure-A significant concern in elders?
Gupta B; Acharya A; Pelekos G; Gopalakrishnan D; Kolokythas A
Gerodontology; 2017 Dec; 34(4):505-507. PubMed ID: 28744899
[TBL] [Abstract][Full Text] [Related]
11. Association of Systemic Conditions with Dental Implant Failures in 6,384 Patients During a 31-Year Follow-up Period.
Carr AB; Revuru VS; Lohse CM
Int J Oral Maxillofac Implants; 2017; 32(5):1153-1161. PubMed ID: 28906509
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality.
Ried LD; Jia H; Feng H; Cameon R; Wang X; Tueth M; Wu SS
Ann Pharmacother; 2011 Jul; 45(7-8):888-97. PubMed ID: 21750310
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors as a risk factor for dental implant failure: a retrospective clinical study.
Rodríguez-Pena K; Salgado-Peralvo ÁO; Kewalramani N; Suárez-Quintanilla JA; Suárez-Quintanilla JM
Br J Oral Maxillofac Surg; 2022 Dec; 60(10):1347-1352. PubMed ID: 36411146
[TBL] [Abstract][Full Text] [Related]
14. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Labos C; Dasgupta K; Nedjar H; Turecki G; Rahme E
CMAJ; 2011 Nov; 183(16):1835-43. PubMed ID: 21948719
[TBL] [Abstract][Full Text] [Related]
15. Early Implant Failure Associated With Patient Factors, Surgical Manipulations, and Systemic Conditions.
Carr AB; Arwani N; Lohse CM; Gonzalez RLV; Muller OM; Salinas TJ
J Prosthodont; 2019 Jul; 28(6):623-633. PubMed ID: 30350385
[TBL] [Abstract][Full Text] [Related]
16. Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study.
Chu CS; Chou PH; Lin CH; Cheng C; Tsai CJ; Lan TH; Huang MW; Nestadt G
PLoS One; 2016; 11(9):e0162239. PubMed ID: 27612144
[TBL] [Abstract][Full Text] [Related]
17. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
18. Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
Kwak N; Lee H; Kim BK; Yu YM; Kang HY
J Gastroenterol Hepatol; 2024 Feb; 39(2):280-288. PubMed ID: 37961007
[TBL] [Abstract][Full Text] [Related]
19. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
Sun JW; Hernández-Díaz S; Haneuse S; Bourgeois FT; Vine SM; Olfson M; Bateman BT; Huybrechts KF
JAMA Psychiatry; 2021 Jan; 78(1):91-100. PubMed ID: 32876659
[TBL] [Abstract][Full Text] [Related]
20. Risks of suicide and poisoning among elderly patients prescribed selective serotonin reuptake inhibitors: a retrospective cohort study.
Rahme E; Dasgupta K; Turecki G; Nedjar H; Galbaud du Fort G
J Clin Psychiatry; 2008 Mar; 69(3):349-57. PubMed ID: 18278986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
